Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study.
about
Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's diseaseMembrane attack by complement: the assembly and biology of terminal complement complexesComplement: a key system for immune surveillance and homeostasisRole of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson's disease.Inflammation as a causative factor in the aetiology of Parkinson's diseaseThe Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.Complement expression in the retina is not influenced by short-term pressure elevation.Parkinson's disease dementia and potential therapeutic strategies.The Lewy body in Parkinson's disease and related neurodegenerative disorders.α-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration.Innate immunity and neuroinflammation.Molecular changes in the postmortem parkinsonian brain.Therapeutic complement inhibition: a promising approach for treatment of neuroimmunological diseases.Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD).Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson's disease.Plaque complement activation and cognitive loss in Alzheimer's disease.Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre.Biological Implications of Differential Expression of Mitochondrial-Shaping Proteins in Parkinson's Disease.Alternative Splicing of Alpha- and Beta-Synuclein Genes Plays Differential Roles in Synucleinopathies.Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing.Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress.
P2860
Q26849232-CA6F4BB7-3ABF-43CC-8F91-AF72F84E91A5Q26997385-DAEC7D56-C75A-4BE3-A532-ED1B1070C791Q29615484-1F3D9788-98CA-4D6E-B881-CA8FC888AB2CQ35510197-C55ECC08-BCF5-4148-9BB6-9BF750A8ADFBQ35532413-2748AC79-0A66-44A0-B7ED-61060382799AQ36052641-215F1D74-D971-4105-A400-8AEE387915E7Q37003482-C149614D-F301-40E5-A4F1-50FFA57403C5Q37091310-F94D3AD5-1B76-4065-84BE-D7E0CF1AC692Q37553920-EBF575B3-207F-4B6B-8391-B7F5789B9A94Q37825631-8A1589CB-4B4A-4249-97CD-1E92A2886831Q38012653-5FFFA62B-0E27-4AA0-9052-7F12DDBD1031Q38038123-62B468B6-FF62-4807-AC53-9076F8331F1BQ38120744-9866B8B5-5B6F-424C-979A-59C1661CCFD5Q38887346-885859D4-9884-43EF-88E7-BBE1B46AD2D7Q39090725-433BEF7C-D267-4EEA-AE15-A5E552F5C5FDQ39901740-485BF2C3-46AC-45C9-9C44-E54D4F92E332Q41917715-47BB9B3E-AC2B-4F3D-88FD-5B3331E323B7Q43111970-24173A14-84A9-4317-8B78-C2C148947D89Q44207492-1173BB00-1885-4D75-BF35-32D3A38D1461Q47265377-E7027921-1348-49D0-9904-29F792393BE3Q47839926-91E06FD1-4EBB-4FC2-8AFE-5A6A8ED096F9Q55360734-2574EAC1-52FD-4EDE-B1FC-A440E4C72173Q55505826-E062018F-B967-448C-A228-4395704A3E96
P2860
Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Complement activation in the P ...... : an immunocytochemical study.
@en
type
label
Complement activation in the P ...... : an immunocytochemical study.
@en
prefLabel
Complement activation in the P ...... : an immunocytochemical study.
@en
P2093
P2860
P356
P1476
Complement activation in the P ...... : an immunocytochemical study.
@en
P2093
David A Loeffler
Dianne M Camp
Stephanie B Conant
P2860
P2888
P356
10.1186/1742-2094-3-29
P577
2006-10-19T00:00:00Z
P5875
P6179
1000861434